• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Efficacy comparison of intravenous and subcutaneous recombinant human erythropoietin administration in hemodialysis patients.

作者信息

Bommer J, Barth H P, Zeier M, Mandelbaum A, Bommer G, Ritz E, Reichel H, Novack R

机构信息

I. Medizinische Universitätsklinik Heidelberg, FRG.

出版信息

Contrib Nephrol. 1991;88:136-43. doi: 10.1159/000419523.

DOI:10.1159/000419523
PMID:2040175
Abstract
摘要

相似文献

1
Efficacy comparison of intravenous and subcutaneous recombinant human erythropoietin administration in hemodialysis patients.血液透析患者静脉注射与皮下注射重组人促红细胞生成素的疗效比较
Contrib Nephrol. 1991;88:136-43. doi: 10.1159/000419523.
2
Recombinant human erythropoietin in anemic patients on maintenance hemodialysis: comparison between intravenous and subcutaneous administration.重组人促红细胞生成素用于维持性血液透析贫血患者：静脉注射与皮下注射的比较
Nephron. 1991;57(4):485-6. doi: 10.1159/000186357.
3
Subcutaneous versus intravenous recombinant human erythropoietin administration in hemodialysis patients.
Nephron. 1993;63(1):113-4. doi: 10.1159/000187156.
4
Comparison between intravenous recombinant human erythropoietin and subcutaneous injection in Thai hemodialysis patients.
J Med Assoc Thai. 2004 Sep;87(9):1041-7.
5
Variations of recombinant human erythropoietin application in hemodialysis patients.重组人促红细胞生成素在血液透析患者中的应用差异。
Contrib Nephrol. 1989;76:149-56; discussion 156-8. doi: 10.1159/000417891.
6
Comparison of subcutaneous and intravenous recombinant human erythropoietin for anemia in hemodialysis patients with significant comorbid disease.皮下注射与静脉注射重组人促红细胞生成素治疗合并严重疾病的血液透析患者贫血的比较
Am J Nephrol. 1992;12(5):303-10. doi: 10.1159/000168464.
7
[Comparison of the efficacy and tolerance of recombinant human erythropoietin between intravenous and subcutaneous administration in chronic hemodialysis. Prospective multicenter study].
Nephrologie. 1992;13(2):87-92.
8
Crossover comparison of intravenous and subcutaneous recombinant human erythropoietin in a small haemodialysis unit.小型血液透析单位中静脉注射与皮下注射重组人促红细胞生成素的交叉比较
Nephrol Dial Transplant. 1998 Nov;13(11):2979-80. doi: 10.1093/ndt/13.11.2979.
9
Painless subcutaneous erythropoietin (rHuEpo) injection--is it the panacea?无痛皮下注射促红细胞生成素（rHuEpo）——它是万灵药吗？
Nephrol Dial Transplant. 1994;9(9):1224-5.
10
Efficacy of intravenous and subcutaneous erythropoietin in patients on hemodialysis and continuous ambulatory peritoneal dialysis.
Changgeng Yi Xue Za Zhi. 1994 Jun;17(2):105-12.

引用本文的文献

1
Clinical pharmacokinetics and pharmacodynamics of erythropoiesis-stimulating agents.促红细胞生成素刺激剂的临床药代动力学和药效学。
Clin Pharmacokinet. 2013 Dec;52(12):1063-83. doi: 10.1007/s40262-013-0098-x.
2
Recombinant human erythropoietin for the treatment of renal anaemia in children: no justification for bodyweight-adjusted dosage.
Clin Pharmacokinet. 2004;43(1):57-70. doi: 10.2165/00003088-200443010-00004.
3
Pharmacokinetics/pharmacodynamics of recombinant human erythropoietins in doping control.重组人促红细胞生成素在兴奋剂检测中的药代动力学/药效学
Sports Med. 2003;33(4):301-15. doi: 10.2165/00007256-200333040-00004.
4
Perioperative erythropoietin administration in patients with gastrointestinal tract cancer: prospective randomized double-blind study.胃肠道癌患者围手术期应用促红细胞生成素：前瞻性随机双盲研究
Ann Surg. 2003 Mar;237(3):417-21. doi: 10.1097/01.SLA.0000055275.38740.56.
5
Predicting the time course of haemoglobin in children treated with erythropoietin for renal anaemia.预测接受促红细胞生成素治疗肾性贫血患儿血红蛋白的时间进程。
Br J Clin Pharmacol. 1998 Nov;46(5):461-6. doi: 10.1046/j.1365-2125.1998.00797.x.
6
Epoetin beta. A review of its pharmacological properties and clinical use in the management of anaemia associated with chronic renal failure.β-促红细胞生成素。其药理学特性及在治疗慢性肾衰竭相关性贫血中的临床应用综述。
Drugs. 1996 Feb;51(2):299-318. doi: 10.2165/00003495-199651020-00008.
7
Pharmacokinetics of recombinant human erythropoietin applied subcutaneously to children with chronic renal failure.
Pediatr Nephrol. 1993 Feb;7(1):61-4. doi: 10.1007/BF00861571.
8
The pharmacokinetics of recombinant human erythropoietin after subcutaneous injection at different sites.重组人促红细胞生成素在不同部位皮下注射后的药代动力学。
Eur J Clin Pharmacol. 1994;46(4):333-7. doi: 10.1007/BF00194401.
9
Controversies in determination of epoetin (recombinant human erythropoietin) dosages.
Clin Pharmacokinet. 1992 Jun;22(6):409-15. doi: 10.2165/00003088-199222060-00001.